Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
British Journal of Pharmacology
|
July 23, 2019
The novel cannabinoid CB<sub>1</sub> receptor agonist AM11101 increases food intake in female rats
Sean B Ogden, Michael S Malamas, Alexandros Makriyannis, et al.
Scientific Reports
|
March 30, 2022
Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase
Othman Benchama, Sergiy Tyukhtenko, Michael S Malamas, et al.
International Journal of Molecular Sciences
|
November 14, 2023
Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
Sofia Papadogkonaki, Dimitris Spyridakos, Emmanouela Lapokonstantaki, et al.
Scientific Reports
|
December 23, 2022
Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA)
Othman Benchama, Michael S Malamas, Kulkarni Praveen, et al.
Experimental Eye Research
|
September 26, 2020
Endocannabinoid metabolism and transport as targets to regulate intraocular pressure
Sally Miller, Laura Daily, Vijai Dharla, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2005
Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones
Robert E McDevitt, Michael S Malamas, Eric S Manas, et al.
Bioorganic & Medicinal Chemistry
|
August 21, 2018
Oximes short-acting CB1 receptor agonists
Michael S Malamas, Jimit Girish Raghav, Xiaoyu Ma, et al.
Neuropharmacology
|
November 16, 2018
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward
Claudia Sagheddu, Maria Scherma, Mauro Congiu, et al.
Neuropharmacology
|
January 15, 2021
The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity
Despina Kokona, Dimitris Spyridakos, Manolis Tzatzarakis, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2021
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance
Mauro Congiu, Laura Micheli, Michele Santoni, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
British Journal of Pharmacology
|
July 23, 2019
The novel cannabinoid CB<sub>1</sub> receptor agonist AM11101 increases food intake in female rats
Sean B Ogden, Michael S Malamas, Alexandros Makriyannis, et al.
Scientific Reports
|
March 30, 2022
Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase
Othman Benchama, Sergiy Tyukhtenko, Michael S Malamas, et al.
International Journal of Molecular Sciences
|
November 14, 2023
Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
Sofia Papadogkonaki, Dimitris Spyridakos, Emmanouela Lapokonstantaki, et al.
Scientific Reports
|
December 23, 2022
Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA)
Othman Benchama, Michael S Malamas, Kulkarni Praveen, et al.
Experimental Eye Research
|
September 26, 2020
Endocannabinoid metabolism and transport as targets to regulate intraocular pressure
Sally Miller, Laura Daily, Vijai Dharla, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2005
Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones
Robert E McDevitt, Michael S Malamas, Eric S Manas, et al.
Bioorganic & Medicinal Chemistry
|
August 21, 2018
Oximes short-acting CB1 receptor agonists
Michael S Malamas, Jimit Girish Raghav, Xiaoyu Ma, et al.
Neuropharmacology
|
November 16, 2018
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward
Claudia Sagheddu, Maria Scherma, Mauro Congiu, et al.
Neuropharmacology
|
January 15, 2021
The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity
Despina Kokona, Dimitris Spyridakos, Manolis Tzatzarakis, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2021
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance
Mauro Congiu, Laura Micheli, Michele Santoni, et al.
Page
of 4